e-learning
resources
Berlin 2008
Sunday, 05.10.2008
EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients' treatment?
A. Dirksen (Hellerup, Denmark)
Source:
Annual Congress 2008 - EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency
Session:
EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency
Session type:
Evening Symposium
Number:
1497
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Dirksen (Hellerup, Denmark). EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients' treatment?. Annual Congress 2008 - EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Disease management program COPD in Germany: benefit for the patient in respect of GOLD-stages?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Can pulmonary rehabilitation (PR) provide the patient's ability to better cope COPD? – A longitudinal design
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014
"Trial-skilled" patients: How big the improvement in cooperation?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
We provided patients with patients oriented diagnosis and treatment advice from their lung assessments using an algorithm. It was feasible and in general well appreciated by our patients
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Prescriptions for treatment in patients with PCD: does clinical routine match recommendations?
Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum
Year: 2020
Quality of life in lung cancer patients: preliminary results of a multi-professional interview for diagnosis disclosure (MIDD)
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Sarcoidosis treatment and outcomes: what is most important to patients?
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Is integrated disease management of COPD effective? Results of the RECODE cluster randomized controlled trial in real world patients
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept